OTR3

About:

OTR3 is a biotechnology company.

Top Investors: EASME - EU Executive Agency for SMEs

Description:

OTR3 is a biotechnology company founded by Professors Denis Barritault and Jean-Pierre Caruelle† from the University of Paris-East Créteil in 2000, laureates of the French national competition for the creation of the best innovative company. Known for their pioneering work on growth factors – the discovery of FGF, HARP/PTN – they invented the RGTA® Technology (ReGeneraTing Agents), a new therapeutic class in regenerative medicine.

Total Funding Amount:

3.4M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2000-01-01

Contact Email:

contact(AT)otr3.com

Founders:

Denis Barritault, Jean-Pierre Caruelle

Number of Employees:

11-50

Last Funding Date:

2018-10-01

IPO Status:

Private

Industries: